JP2001238608A - Feed for poultry farming - Google Patents

Feed for poultry farming

Info

Publication number
JP2001238608A
JP2001238608A JP2000055751A JP2000055751A JP2001238608A JP 2001238608 A JP2001238608 A JP 2001238608A JP 2000055751 A JP2000055751 A JP 2000055751A JP 2000055751 A JP2000055751 A JP 2000055751A JP 2001238608 A JP2001238608 A JP 2001238608A
Authority
JP
Japan
Prior art keywords
salmonella
feed
mannose
added
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000055751A
Other languages
Japanese (ja)
Inventor
Genichi Yoshikawa
源一 吉川
Katsuyuki Mukai
克之 向井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unitika Ltd
Original Assignee
Unitika Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unitika Ltd filed Critical Unitika Ltd
Priority to JP2000055751A priority Critical patent/JP2001238608A/en
Publication of JP2001238608A publication Critical patent/JP2001238608A/en
Pending legal-status Critical Current

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide a feed for poultry farming that can reduce bacterial infection, for example, salmonellosis. SOLUTION: The objective feed for poultry farming characteristically comprises a mannose-including powder and an attenuated vaccine.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、飼料のサルモネラ
等の細菌汚染及び鶏のサルモネラ等の細菌感染を軽減す
る養鶏用飼料に関するものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a poultry feed for reducing bacterial contamination such as Salmonella in feed and bacterial infection such as Salmonella in chickens.

【0002】[0002]

【従来の技術】1989年以降サルモネラ・エンテリテ
ィデス(SE)が原因とされる食中毒が急増し、サルモネ
ラの汚染も養鶏業界に広がっている。従来、逆性消毒薬
等が鶏舎の消毒を目的に使用されてきたが、抜本的解決
策がないのが現状である。海外においては、ワクチンを
使用しているが、我が国においては平成10年4月より許
可されたが、腸内のサルモネラの感染を阻止するまでに
到っていない。また、特開平10−215790号公報
においては、熱処理や生菌剤やオリゴ糖及び酸性化剤を
添加した養鶏用飼料他が報告されている。さらに、マン
ノース含有コプラミールを摂取させることにより、サル
モネラの鶏の腸管接着が阻害されることが、WO99/08544
号公報に報告されている。
BACKGROUND OF THE INVENTION Since 1989, food poisoning caused by Salmonella enteritides (SE) has rapidly increased, and contamination of Salmonella has spread to the poultry industry. Conventionally, an inverse disinfectant or the like has been used for disinfection of poultry houses, but at present there is no drastic solution. Overseas, vaccines are used. In Japan, the vaccine has been approved since April 1998, but it has not yet reached the point of preventing intestinal Salmonella infection. Japanese Patent Application Laid-Open No. 10-215790 reports on poultry feeds and the like to which heat treatment, a probiotic agent, an oligosaccharide and an acidifying agent are added. Furthermore, the ingestion of mannose-containing copra meal inhibits the intestinal adhesion of Salmonella chickens, WO99 / 08544
No. is reported in the official gazette.

【0003】[0003]

【発明が解決しようとする課題】しかし、サルモネラに
対するワクチンは鶏の腸内から体内へのサルモネラの移
行を阻止するが、サルモネラの腸内の定着は防ぐことは
できないという問題があった。特開平10−21579
0号報の実施例では、基礎飼料にマンナンオリゴ糖を0.
15%添加しており、高濃度だと下痢を発症する可能性が
あり、また経済的に高価であるという問題があった。さ
らに、WO99/08544号公報の実施例では、基礎飼
料にマンノ−ス含有コプラミールを1質量%添加してい
るが、サルモネラ投与後6日目で0日目にくらべ、糞便
中のサルモネラ数は1/10にしか減少せず、また経済
的に高価であるという問題があった。そこで、本発明
は、飼料のサルモネラ等の細菌汚染及びその飼料を摂取
した採卵鶏及びブロイラ−のサルモネラ等の細菌感染を
微量の添加濃度で軽減する養鶏用飼料を提供することを
目的とするものである。
However, there is a problem that the vaccine against Salmonella inhibits the transfer of Salmonella from the intestine of the chicken to the body, but cannot prevent the colonization of Salmonella in the intestine. JP-A-10-21579
In the example of the No. 0 report, mannan oligosaccharide was added to the basal feed at a concentration of 0.
There is a problem that if added at a high concentration, diarrhea may occur and it is economically expensive. Furthermore, in the example of WO99 / 08544, 1% by mass of mannose-containing copra meal was added to the basal feed, but the number of salmonella in feces was 1 on day 6 after administration of Salmonella compared to day 0. However, there is a problem that the cost is only reduced to / 10 and the cost is high. Therefore, an object of the present invention is to provide a poultry feed that reduces bacterial contamination of salmonella and the like in feed and bacterial infection of salmonella and the like of laying hens and broilers that ingested the feed with a small amount of added concentration. It is.

【0004】[0004]

【課題を解決するための手段】本発明者らは、このよう
な課題を解決するために、種々の添加剤他を鋭意検討し
た結果、養鶏用飼料にマンノース含有粉体及び生菌剤を
同時に添加することによって単独で添加した場合よりも
相乗作用によりサルモネラ排菌効果が高まり、上記課題
を解決できることを見い出し、本発明を完成するに至っ
た。すなわち、本発明はマンノース含有粉体及び生菌剤
を添加したことを特徴とする養鶏用飼料を要旨とするも
のである。
Means for Solving the Problems The present inventors have conducted intensive studies on various additives and the like in order to solve such problems, and as a result, the mannose-containing powder and the probiotic agent were simultaneously added to poultry feed. The present inventors have found that the effect of salmonella eradication is enhanced by the synergistic effect of the addition as compared with the case where it is added alone, and it has been found that the above-mentioned problem can be solved, and the present invention has been completed. That is, the gist of the present invention is a feed for poultry farming, characterized by adding a mannose-containing powder and a probiotic agent.

【0005】[0005]

【発明の実施の形態】以下、本発明を詳細に説明する。
近代的な養鶏では雛は親鶏とは別々に飼育され、親鶏の
正常な腸内細菌叢を糞便を通して直接摂取することがで
きないため、雛の腸内細菌は孵化後2週間は未発達であ
り、サルモネラ等の有害細菌の攻撃を受けやすい。その
ため、乳酸菌、酪酸菌、ビフィズス菌、さらにCE(Comp
etitive Exclusion:競合排除)製剤等の生菌剤を飼料に
添加することにより、鶏に有用菌を提供し、有害細菌の
定着を阻害する効果が報告されている。本発明で用いら
れる生菌剤としては、乳酸菌、酪酸菌、ビフィズス菌、
CE製剤などが挙げられ、CE製剤としては、例えばアヴィ
ガ−ド(バイエル(株))、インテクリ−ン(伊藤忠飼
料(株))、ブロイラクト(藤沢薬品(株))、デロ−
テ29(共立商事(株))のようなものが挙げられる。飼
料に添加する生菌剤の濃度は、マンノース含有粉体と同
時に添加する場合、通常添加している濃度と同様に、10
質量%〜50質量%添加すればよい。
BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail.
In modern poultry farms, chicks are bred separately from the parent chicken and the normal intestinal flora of the parent chicken can not be directly ingested through feces, so the intestinal bacteria of the chick are undeveloped for two weeks after hatching. Yes, it is susceptible to attack by harmful bacteria such as Salmonella. Therefore, lactic acid bacteria, butyric acid bacteria, bifidobacteria, and CE (Comp
It has been reported that the addition of live bacterial agents such as etitive Exclusion preparations to feeds provides useful bacteria to chickens and inhibits colonization of harmful bacteria. The probiotic agents used in the present invention include lactic acid bacteria, butyric acid bacteria, bifidobacteria,
Examples of CE preparations include, for example, avigard (Bayer Co., Ltd.), inteclean (Itochu Feed Co., Ltd.), broilact (Fujisawa Pharmaceutical Co., Ltd.), Delro-
TE29 (Kyoritsu Shoji Co., Ltd.). When added at the same time as the mannose-containing powder, the concentration of the probiotic agent added to the feed should be 10
What is necessary is just to add 50 mass%-50 mass%.

【0006】本発明で用いられるマンノース含有粉体と
は、コプラミール、パーム核ミール、グァーガム、ロー
カストビーンガム、こんにゃく粉等のマンナン、ガラク
トマンナン、グルコマンナン含有物をヘミセルラーゼ処
理したものである。コプラミールとは、ココヤシ果実内
部の核肉を乾燥させて得られるヤシ油原料であるコプラ
からヤシ油を抽出した後の残さ粉砕物であり、通常、約
28質量%のマンナンを含んでいる。パーム核ミールと
は、アブラヤシの種子のパーム核(Palm Kernel)から
パーム核油を抽出した後の残渣粉砕物であり、通常、約
40質量%のマンナンを含んでいる。グァーガム、ロー
カストビーンガム、こんにゃく粉は食品素材や増粘剤と
して用いられている。
The mannose-containing powder used in the present invention is a mannose, galactomannan, or glucomannan-containing substance such as copra meal, palm kernel meal, guar gum, locust bean gum, konjac powder or the like, which is treated with hemicellulase. Copra meal is a pulverized residue obtained by extracting coconut oil from copra, which is a coconut oil raw material obtained by drying core meat inside coconut fruit, and usually contains about 28% by mass of mannan. Palm kernel meal is a crushed residue of palm kernel oil extracted from palm kernel of oil palm seeds (Palm Kernel), and usually contains about 40% by mass of mannan. Guar gum, locust bean gum, and konjac powder are used as food ingredients and thickeners.

【0007】ヘミセルラーゼとは、植物細胞壁において
セルロースと結合して存在する多糖であるヘミセルロー
スに対して作用する酵素のことであり、マンナン、ガラ
クトマンナン、グルコマンナン含有物に作用してマンノ
ースを遊離するものであれば特に限定されず、マンナナ
ーゼ(マンナーゼ)、マンノシダーゼ等のマンナン分解
酵素が挙げられる。このような酵素の由来としては、枯
草菌(Bacillus subtilis)、糸状菌
(Aspergillus aculeatus、A.
awamori、A.niger,A.usamii、
Humicola insolens、Trichod
erma harzianum、T.koningi、
T.longibrachiatum、T.virid
e)、担子菌(Corticium、Pycnopor
us coccineus)等が挙げられるが、Asp
ergillus由来の酵素が好適である。その中でも
特にAspergillus niger由来のマンナ
ナーゼが好ましい。
[0007] Hemicellulase is an enzyme that acts on hemicellulose, a polysaccharide that is present in plant cell walls by binding to cellulose, and that acts on substances containing mannan, galactomannan, and glucomannan to release mannose. It is not particularly limited as long as it is a mannanase (mannanase) and a mannan degrading enzyme such as mannosidase. Examples of the origin of such enzymes include Bacillus subtilis and filamentous fungi (Aspergillus aculeatus, A. et al.
awamori, A. et al. niger, A .; usamii,
Humicola insolens, Trichod
erma harzianum, T .; koningi,
T. longibrachiatum, T .; virid
e), Basidiomycetes (Corticium, Pycnopor)
us coccineus), and Asp.
Preferred are enzymes from ergillus. Among them, mannanase derived from Aspergillus niger is particularly preferred.

【0008】これらのヘミセルラーゼは上記の菌株を培
養した培養上清もしくは菌体中に生産されるが、これら
のヘミセルラーゼを含有するいかなる画分を使用しても
よい。また、必要に応じてこれらのヘミセルラーゼを含
有する画分を常法により精製あるいは部分精製したもの
を使用してもよい。また、セルロシンHC100、セル
ロシンHC、セルロシンTP25、セルロシンGM5
(以上阪急バイオインダストリー株式会社製)、スミチ
ームAC、スミチームAC−L、スミチームACH(以
上新日本化学工業株式会社製)、ガマナーゼ(ノボノル
ディスクインダストリー社製)等の市販の酵素も使用す
ることができる。飼料に添加するマンノース含有粉体の
濃度は、生菌剤と同時に添加する場合、0.001〜2
質量%、好ましくは、0.005〜1質量%であればよ
く、マンノ−ス濃度として0.0001〜0.2質量%、
好ましくは、0.0005〜0.1質量%含有すればよ
い。
[0008] These hemicellulases are produced in the culture supernatant or cells of the above strains, and any fraction containing these hemicellulases may be used. If necessary, the fraction containing these hemicellulases may be purified or partially purified by a conventional method. Cellulosin HC100, cellulosin HC, cellulosin TP25, cellulosin GM5
Commercial enzymes such as Sumiteam AC, Sumiteam AC-L, Sumiteam ACH (Shin Nippon Chemical Co., Ltd.) and Gamanase (Novo Nordisk Industries) can also be used. it can. When the mannose-containing powder is added to the feed at a concentration of 0.001-2,
% By mass, preferably 0.005 to 1% by mass, and a mannose concentration of 0.0001 to 0.2% by mass.
Preferably, the content is 0.0005 to 0.1% by mass.

【0009】[0009]

【実施例】以下、実施例により本発明を具体的に説明す
る。なお,本発明はこれらの実施例に限定されるもので
はない。 参考例1 マンノース含有粉体の調製 セルロシンGM5(阪急バイオインダストリー株式会社
製マンナナーゼ,力価10,000ユニット/g)0.
3gを水100mLに懸濁し、コプラミール100g
(脂肪分10質量%,水分7.2質量%)に均一になる
ように噴霧したのち、60℃で18時間放置した。反応
終了後、真空乾燥機(ヤマト株式会社製,Vaccum Dryin
g Oven DP32)にて80℃、24時間真空乾燥し、マン
ノース含有粉体を得た。この目的物中の糖成分の分析
は、高速液体カラムクロマトグラフィーによりおこなっ
た。分析用カラムはバイオラッド社製アミネックスHP
X−87Pを用いた。カラム温度は85℃、流速0.6
ml/minとし、水で溶出をおこなった。糖の検出は
示差屈折計を用い、標準品の定量値からマンノースの含
有量を求めた。上記の反応後の粉末を分析した結果、1
00g中に13gのマンノースが蓄積していた。水分含
量は12.0質量%であった。
The present invention will be described below in detail with reference to examples. Note that the present invention is not limited to these examples. Reference Example 1 Preparation of powder containing mannose Cellulosin GM5 (mannanase manufactured by Hankyu Bio-Industry Co., Ltd., titer 10,000 units / g)
3 g is suspended in 100 mL of water, and 100 g of copra meal is suspended.
(Fat content: 10% by mass, water content: 7.2% by mass), and then left at 60 ° C. for 18 hours. After completion of the reaction, a vacuum dryer (Vaccum Dryin, manufactured by Yamato Corporation)
g Oven DP32) under vacuum at 80 ° C for 24 hours to obtain a mannose-containing powder. The analysis of the sugar component in the target product was performed by high performance liquid column chromatography. Analytical column is Aminex HP manufactured by Bio-Rad
X-87P was used. Column temperature 85 ° C, flow rate 0.6
It was eluted with water at a rate of ml / min. The sugar was detected using a differential refractometer, and the mannose content was determined from the quantitative value of the standard product. As a result of analyzing the powder after the above reaction, 1
13 g of mannose had accumulated in 00 g. The water content was 12.0% by mass.

【0010】実施例1 5週齢の白レグ種採卵鶏(ジュリア)20羽に、表1に
示す組成の配合飼料に、参考例1で調整したマンノ−ス
含有粉体0.02質量%と生菌剤(CE製剤、商品名アヴ
ィガ−ド、バイエル(株))0.002質量%添加した
配合飼料を、25日間にわたり、1日1羽当り0.1kg
(またはト−タル供与量2.5kg)不断供与した。
Example 1 Twenty five-week-old white-legged egg laying hens (Julia) were mixed with 0.02% by mass of the mannose-containing powder prepared in Reference Example 1 in a compound feed having the composition shown in Table 1. 0.1 kg per bird per day for 25 days with a mixed feed supplemented with 0.002% by mass of a probiotic agent (CE preparation, trade name: Avigad, Bayer)
(Or 2.5 kg of total donation).

【0011】[0011]

【表1】 [Table 1]

【0012】飼料供与後、18日目にサルモネラ菌(農
林水産省家畜衛生試験場より分与されたSalmonella Ent
eritidis野生株)を8.0x105個/mlを含む菌液1mlを、カ
テーテルにより強制経口投与した。飼料供与後14日(コ
ントロール)、及びサルモネラ投与後1日、3日、及び7
日の朝に排出された盲腸糞を個体別に採取し、以下のよ
うにしてサルモネラ数を測定した。
On the 18th day after feeding, Salmonella bacteria (Salmonella Ent.
eritidis wild strain) was forcibly orally administered via a catheter with 1 ml of a bacterial solution containing 8.0 × 10 5 cells / ml. 14 days after feeding (control), 1 day, 3 days and 7 days after Salmonella administration
Cecal feces discharged on the morning of the day were collected for each individual, and the number of Salmonella was measured as follows.

【0013】(サルモネラ数の測定法)盲腸糞1gを滅菌
リン酸緩衝生理食塩液を加えて10倍に希釈し、十分混
合して試料原液とした。次いで、試料原液を滅菌生理食
塩液を用いて公比10で段階希釈し100倍希釈液及び1
000倍希釈液を調製した。試料原液、100倍希釈及
び1000倍希釈液を、それぞれSS寒天平板培地及びブ
リリアントグリ−ン寒天平板培地に0.1mlずつ塗沫し
て37℃で24時間培養し、各平板培地に生育した定型
的集落を計測した。さらに、集落より釣菌してリジン脱
炭酸試験用、SIM寒天培地及びTSI寒天培地(クリグラ−
培地の変法で腸内細菌確認用培地)に接種して37℃で
24時間培養して性状の確認を行い、この集落がサルモ
ネラと認められた場合には、サルモネラ免疫血清を用い
て血清型の確認を行い、サルモネラO9群と認められた集
落数に、試料原液あるいは希釈液の希釈倍率を乗じて糞
1g当りのサルモネラ菌数を算出した。
(Measurement method of Salmonella number) 1 g of cecal feces was diluted 10-fold with sterile phosphate buffered saline and mixed well to prepare a sample stock solution. Next, the sample stock solution was serially diluted with a sterile physiological saline solution at a common ratio of 10 to give a 100-fold diluted solution and 1
A 000-fold dilution was prepared. 0.1 ml each of the sample stock solution, 100-fold dilution and 1000-fold dilution was spread on SS agar plate medium and brilliant green agar plate medium, cultured at 37 ° C. for 24 hours, and grown on each plate medium. The target settlement was measured. Furthermore, the bacteria were collected from the colonies and used for lysine decarboxylation test, SIM agar medium and TSI agar medium (Cliggra
Inoculated in a modified medium for intestinal bacteria) and cultured at 37 ° C. for 24 hours to confirm the properties. If the colony is found to be Salmonella, the serotype is determined using Salmonella immune serum. Was confirmed, and the number of colonies recognized as the Salmonella O9 group was multiplied by the dilution ratio of the sample stock solution or diluent to calculate the number of Salmonella bacteria per gram of feces.

【0014】比較例1,2 また、比較のため、上記のマンノ−ス含有粉体0.02
質量%と生菌剤0.002質量%に代えて、マンノ−ス
含有粉体0.02質量%のみ(比較例1)、生菌剤0.0
02質量%のみ(比較例2)を添加した2種類の飼料を
用いて同様にサルモネラの排菌試験を行った。
Comparative Examples 1 and 2 Also, for comparison, the above-mentioned mannose-containing powder 0.02 was used.
% Of mannose-containing powder (Comparative Example 1) instead of 0.002% by mass and
Salmonella eradication test was similarly performed using two kinds of feeds to which only 02% by mass (Comparative Example 2) was added.

【0015】実施例1、比較例1及び2の結果を図1に
示す。図中Aは本発明の飼料を添加した鶏(実施例
1)、Bはマンノ−ス含有粉体0.02質量%のみを添加
した鶏(比較例1)およびCは生菌剤0.002質量%の
み添加した鶏(比較例2)の盲腸糞中のサルモネラ菌の
数を示す。図1は、鶏におけるサルモネラの排菌試験の
結果を示す図であり、縦軸にサルモネラの排菌数の対数
値を、横軸にサルモネラ投与後の日数を示している。以
上の結果から、本発明のマンノース含有粉体及び生菌剤
を添加した飼料は、単独で添加した時よりもサルモネラ
排菌効果に優れていることがわかる。
FIG. 1 shows the results of Example 1 and Comparative Examples 1 and 2. In the figure, A is a chicken to which the feed of the present invention is added (Example 1), B is a chicken to which only 0.02% by mass of the mannose-containing powder is added (Comparative Example 1), and C is a live bacteria agent 0.002. The number of Salmonella in the cecal feces of the chicken (Comparative Example 2) to which only% by mass was added is shown. FIG. 1 is a diagram showing the results of a salmonella eradication test in chickens, in which the vertical axis represents the logarithmic value of the number of salmonella eradications, and the horizontal axis represents the number of days after Salmonella administration. From the above results, it can be seen that the feed to which the mannose-containing powder and the probiotic agent of the present invention are added has a better Salmonella eradication effect than when it is added alone.

【0016】[0016]

【発明の効果】本発明の養鶏用飼料は、サルモネラ等の
細菌感染を軽減する効果だけでなく、1型線毛等を有す
る大腸菌の腸管への接着も阻害し、大腸菌症を防ぐ効果
も有する。
EFFECTS OF THE INVENTION The poultry feed of the present invention not only has the effect of reducing bacterial infections such as Salmonella, but also has the effect of inhibiting adhesion of Escherichia coli having type 1 pili to the intestinal tract and preventing Escherichia coli disease. .

─────────────────────────────────────────────────────
────────────────────────────────────────────────── ───

【手続補正書】[Procedure amendment]

【提出日】平成12年3月14日(2000.3.1
4)
[Submission Date] March 14, 2000 (200.3.1)
4)

【手続補正1】[Procedure amendment 1]

【補正対象書類名】明細書[Document name to be amended] Statement

【補正対象項目名】図面の簡単な説明[Correction target item name] Brief description of drawings

【補正方法】変更[Correction method] Change

【補正内容】[Correction contents]

【図面の簡単な説明】[Brief description of the drawings]

【図1】鶏におけるサルモネラの拝菌試験の結果を示す
図である。
FIG. 1 is a diagram showing the results of a salmonella bacillus test in chickens.

【符号の説明】 A 本発明の飼料を添加した鶏(実施例1) B マンノース含有粉体のみを添加した鶏(比較例1) C 生菌剤のみを添加した鶏(比較例2)[Description of Signs] A Chicken to which the feed of the present invention was added (Example 1) B Chicken to which only mannose-containing powder was added (Comparative Example 1) C Chicken to which only a probiotic agent was added (Comparative Example 2)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 マンノース含有粉体及び生菌剤を添加し
たことを特徴とする養鶏用飼料。
1. A poultry feed to which a mannose-containing powder and a probiotic agent have been added.
JP2000055751A 2000-03-01 2000-03-01 Feed for poultry farming Pending JP2001238608A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2000055751A JP2001238608A (en) 2000-03-01 2000-03-01 Feed for poultry farming

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000055751A JP2001238608A (en) 2000-03-01 2000-03-01 Feed for poultry farming

Publications (1)

Publication Number Publication Date
JP2001238608A true JP2001238608A (en) 2001-09-04

Family

ID=18576820

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000055751A Pending JP2001238608A (en) 2000-03-01 2000-03-01 Feed for poultry farming

Country Status (1)

Country Link
JP (1) JP2001238608A (en)

Similar Documents

Publication Publication Date Title
Ferdous et al. Beneficial effects of probiotic and phytobiotic as growth promoter alternative to antibiotic for safe broiler production
Perić et al. Application of alternative growth promoters in broiler production
Apata Growth performance, nutrient digestibility and immune response of broiler chicks fed diets supplemented with a culture of Lactobacillus bulgaricus
CN104758318B (en) A kind of compound formulation and preparation method thereof reducing diarrhea of weaned piglets rate
JP3292481B2 (en) Mannose-containing feed and production method thereof
Zduńczyk et al. Determinants and effects of postileal fermentation in broilers and turkeys part 1: gut microbiota composition and its modulation by feed additives
KR20080109795A (en) Composition for beverage or food
KR101748368B1 (en) Fermentation feed for domestic animal comprising liquid fermented sulfuric
US20070009503A1 (en) Antibiotic, Compositions Containing the Antibiotic, and Methods for Administering the Antibiotic and/or Said Compositions to Livestock
CN106689673A (en) Feed formula for improving weaned piglet disease resistance and application
CN109475151A (en) Control the immunological regulation of harmful bacteria and growth promotion composition and application thereof in intestinal microbiota
CN108669298A (en) A kind of feeding probiotic microcapsule and its preparation method and application
CN109601734A (en) Feed addictive containing procyanidine and dietary fiber and preparation method thereof and nonreactive pig starter feed product
WO2007034627A1 (en) Additive for animal feed
WO2004080200A1 (en) Probiotic micro-organisms and uses thereof
CN106879826A (en) A kind of animal feed additive comprising plant extracts and organic acid and application
Wiese The potential of pectin to impact pig nutrition and health: feeding the animal and its microbiome
Mirza Probiotics and prebiotics for the health of poultry
EP1862080A1 (en) Protease-resistant bacteriocins produced by lactic acid bacteria and their use in livestock
Tesfaye et al. The effects of probiotics supplementation on milk yield and composition of lactating dairy cows
EP1228699A1 (en) Preparation which contains sorbic acid as a feed additive in animal raising
JP7092785B2 (en) Feed additive preparation, its manufacturing method and usage method
JPH0984529A (en) Cattle and poultry feed containing mannan originated from microorganism
JP2001238608A (en) Feed for poultry farming
JP2003088300A (en) Coconut oil extraction residue and feed containing the same and used for livestock and fowl

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20070219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091006

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100323